Statera Biopharma Inc. (STAB:NASDAQ) shot up at $0.38, a gain of 81.9%. On Wed, Apr 27, 2022, STAB:NASDAQ hit a New 2-Week Low of $0.21. The stock appeared on our News Catalysts scanner on Wed, Apr 27, 2022 at 04:55 PM in the 'AGREEMENT' category. From Thu, Apr 14, 2022, the stock recorded 0.00% Up Days and 0.00% Green Days
The stock spiked on Wed, Apr 13, 2022 at $0.44 with a volume of 72M+.
About Statera Biopharma Inc. (STAB:NASDAQ)
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 81.87%
- Swvl Holdings Corp (SWVL:NASDAQ), 50.15%
- RCM Technologies, Inc. (RCMT:NASDAQ), 44.57%
- Color Star Technology Co Ltd (CSCW:NASDAQ), 35.44%
- SQZ Biotechnologies Company (SQZ:NYSE), 34.66%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 29.87%
- Werewolf Therapeutics Inc. (HOWL:NASDAQ), 26.49%
- Ra Medical Systems, Inc. (RMED:NYSE), 26.4%
- Archer Aviation Inc. Class A (ACHR:NYSE), 25.14%
- Pitney Bowes Inc. (PBI:NYSE), 23.43%